2019
DOI: 10.1007/s10856-019-6249-3
|View full text |Cite
|
Sign up to set email alerts
|

In vitro and in vivo evaluation of chitosan scaffolds combined with simvastatin-loaded nanoparticles for guided bone regeneration

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
13
1

Year Published

2019
2019
2022
2022

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 28 publications
(15 citation statements)
references
References 47 publications
1
13
1
Order By: Relevance
“…Since the IL‒6 can be involved in many pathways [38] and its role in differentiation was already demonstrated [6], we can suggest a role for this interleukin in the bone formation happening in our experimental model. On the other hand, the ability of chitosan, whose modified form, Chitlac, coats the thermosets, to promote osteogenesis is so largely proven, that it has been recently studied in combination with other biomaterials in bone regeneration [39,40].…”
Section: Discussionmentioning
confidence: 99%
“…Since the IL‒6 can be involved in many pathways [38] and its role in differentiation was already demonstrated [6], we can suggest a role for this interleukin in the bone formation happening in our experimental model. On the other hand, the ability of chitosan, whose modified form, Chitlac, coats the thermosets, to promote osteogenesis is so largely proven, that it has been recently studied in combination with other biomaterials in bone regeneration [39,40].…”
Section: Discussionmentioning
confidence: 99%
“…The new bone formation was more evident in CH-Ca-SV, with various mineralization foci being detected not only at the borders but also inside the scaffold structure. The potential of SV as a biological cue in cell-homing strategies has been demonstrated by previous in vivo studies in which SV-loaded scaffolds improved critical-size bone defect regeneration as well as hastened the fracture-healing and union process (Xue et al 2019; Zhang et al 2019; Hajializade et al 2020). Researchers have found that SV acts as an activator to enhance the regeneration of bone defects along with hydroxyapatite ceramics in different scaffold formulations (Wang et al 2018).…”
Section: Discussionmentioning
confidence: 95%
“…Another strategy to improve and fasten neo-tissue-genesis is to incorporate a bioactive cue on scaffold composition. Local simvastatin (SV) delivery is a strategy successfully used to increase and anchor bone regeneration by creating scaffolds capable of releasing bioactive dosages of this drug at the application site (Li et al 2018; Wang et al 2018; Xue et al 2019; Zhang et al 2019; Hajializade et al 2020). Chitosan has been considered a suitable carrier system for poorly soluble drugs, such as SV, increasing its solubility and thereby its bioavailability for several clinical applications (Selvasudha and Koumaravelou 2017).…”
Section: Introductionmentioning
confidence: 99%
“…However, the low mechanical properties of scaffolds prepared from chitosan make its clinical application problematic. An effective method to overcome chitosan's drawbacks is to blend it with synthetic polymers [249][250][251][252]. Skop et al designed biocompatible chitosan microspheres for the delivery of neural stem cells and growth factors for CNS injuries [253]; another group designed chitosan particles loaded with the drug piperine, reported to have neuroprotective potential against Alzheimer's disease, which successfully targeted specific areas of the brain [254].…”
Section: Chitin and Chitosanmentioning
confidence: 99%